Stiles Financial Services Inc raised its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 4.2% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 14,304 shares of the financial services provider’s stock after buying an additional 583 shares during the quarter. CME Group makes up about 1.1% of Stiles Financial Services Inc’s investment portfolio, making the stock its 25th largest holding. Stiles Financial Services Inc’s holdings in CME Group were worth $3,158,000 at the end of the most recent reporting period.
A number of other hedge funds also recently added to or reduced their stakes in the stock. Norden Group LLC bought a new stake in shares of CME Group during the first quarter valued at about $274,000. Private Advisor Group LLC raised its stake in shares of CME Group by 3.9% during the first quarter. Private Advisor Group LLC now owns 4,592 shares of the financial services provider’s stock valued at $989,000 after purchasing an additional 172 shares in the last quarter. Duality Advisers LP bought a new stake in shares of CME Group during the first quarter valued at about $1,455,000. Envestnet Portfolio Solutions Inc. raised its stake in shares of CME Group by 10.3% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 61,518 shares of the financial services provider’s stock valued at $13,244,000 after purchasing an additional 5,738 shares in the last quarter. Finally, Sciencast Management LP bought a new stake in shares of CME Group during the first quarter valued at about $457,000. 87.75% of the stock is currently owned by institutional investors.
CME Group Stock Up 0.4 %
Shares of CME Group stock opened at $222.94 on Friday. The firm has a market cap of $80.28 billion, a price-to-earnings ratio of 23.35, a P/E/G ratio of 5.61 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $230.36. The stock has a 50-day simple moving average of $221.36 and a 200-day simple moving average of $209.75.
CME Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.06%. CME Group’s dividend payout ratio is 48.37%.
Wall Street Analyst Weigh In
CME has been the topic of several research reports. Deutsche Bank Aktiengesellschaft boosted their price target on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Citigroup boosted their price target on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. The Goldman Sachs Group boosted their price target on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Piper Sandler lifted their price target on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Finally, TD Cowen began coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target on the stock. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $222.73.
View Our Latest Stock Report on CME
Insider Activity
In related news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock worth $3,441,063 in the last three months. 0.30% of the stock is owned by insiders.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- With Risk Tolerance, One Size Does Not Fit All
- The Top 5 Performing S&P 500 Stocks YTD in 2024
- Industrial Products Stocks Investing
- L3Harris: Positioned for Gains With Trump’s Defense Policies
- Differences Between Momentum Investing and Long Term Investing
- Is First Solar’s Earnings Drop a Golden Buying Opportunity?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.